Paper668191
Comparison of the relative cytotoxic effector cell capabilities and the proportions of cells bearing various surface markers in human tonsil and peripheral blood mononuclear cells.
Hunninghake GW and 3 others. Clin Exp Immunol, 1978. Cited by 3 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Comparison of the relative cytotoxic effector cell capabilities and the proportions of cells bearing various surface markers in human tonsil and peripheral blood mononuclear cells. Papers, record 668191. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/668191
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparison of the relative cytotoxic effector cell capabilities and the proportions of cells bearing various surface markers in human tonsil and peripheral blood mononuclear cells.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Monocytes | Major topic |
| Palatine Tonsil | Major topic |
| Antibody-Dependent Cell Cytotoxicity | |
| Cytotoxicity, Immunologic | |
| Humans | |
| Leukocyte Count | |
| Lymphocytes | |
| Rosette Formation |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 301,072 | Characterization of human adenoid cells using surface and functional markers for lymphocyte subpopulations. | Clin Exp Immunol | 1977 | https://conductscience.org/library/papers/301072 | PubMed |
| 2 | 300,304 | Human lymph node lymphocytes fail to effect lysis of antibody-coated target cells. | Clin Exp Immunol | 1977 | https://conductscience.org/library/papers/300304 | PubMed |
| 3 | 824,141 | Antibody-dependent human lymphocytotoxicity: a micro assay system. | Eur J Immunol | 1975 | https://conductscience.org/library/papers/824141 | PubMed |
| 4 | 1,087,314 | The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity. | J Immunol | 1976 | https://conductscience.org/library/papers/1087314 | PubMed |
| 5 | 1,027,718 | Quantitative and qualitative effects of cyclophosphamide administration on circulating polymorphonuclear leucocytes. | Immunology | 1976 | https://conductscience.org/library/papers/1027718 | PubMed |
| 6 | 963,755 | Immunological reactivity of the lung II. Cytotoxic effector function of pulmonary mononuclear cell subpopulations. | Cell Immunol | 1976 | https://conductscience.org/library/papers/963755 | PubMed |
| 7 | 53,242 | Human antibody-dependent cellular cytotoxicity. Isolation and identification of a subpopulation of peripheral blood lymphocytes which kill antibody-coated autologous target cells. | J Clin Invest | 1975 | https://conductscience.org/library/papers/53242 | PubMed |
| 8 | 4,114,496 | Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. | J Exp Med | 1972 | https://conductscience.org/library/papers/4114496 | PubMed |
| 9 | 4,130,071 | Lymphocyte antibody lymphocytolytic interaction (LALI) with special emphasis on HL-A. | Transplant Proc | 1973 | https://conductscience.org/library/papers/4130071 | PubMed |
| 10 | 4,392,749 | Cytotoxic effects of lymphoid cells in vitro. | Adv Immunol | 1969 | https://conductscience.org/library/papers/4392749 | PubMed |
| 11 | 4,617,353 | Lymphocyte mediated cytotoxicity in vitro. Induction and inhibition by humoral antibody and nature of effector cells. | Transplant Rev | 1972 | https://conductscience.org/library/papers/4617353 | PubMed |
| 12 | 52,180 | Antibody-dependent cell-mediated cytotoxicity: heterogeneity of effector cells in human peripheral blood. | Scand J Immunol | 1975 | https://conductscience.org/library/papers/52180 | PubMed |
| 13 | 4,587,500 | Haemolytic activity of human blood monocytes. Lysis of human erythrocytes treated with anti-A serum. | Clin Exp Immunol | 1973 | https://conductscience.org/library/papers/4587500 | PubMed |
| 14 | 4,549,140 | Antibody in the induction and inhibition of lymphocyte cytotoxicity. | Transplant Rev | 1972 | https://conductscience.org/library/papers/4549140 | PubMed |
| 15 | 4,466,607 | The cytotoxic activity of lymphocytes from human lymph in vitro. | Clin Exp Immunol | 1974 | https://conductscience.org/library/papers/4466607 | PubMed |
| 16 | 784,890 | Activation of human B lymphocytes. I. Direct plaque-forming cell assay for the measurement of polyclonal activation and antigenic stimulation of human B lymphocytes. | J Exp Med | 1976 | https://conductscience.org/library/papers/784890 | PubMed |
| 17 | 1,084,017 | Antibody-dependent cell cytoxicity (ADCC). Characterization of 'killer' cells in human lymphoid organs. | Scand J Immunol | 1976 | https://conductscience.org/library/papers/1084017 | PubMed |
| 18 | 1,079,808 | Human bone marrow lymphocytes. I. Distribution of lymphocyte subpopulations in the bone marrow of normal individuals. | J Clin Invest | 1975 | https://conductscience.org/library/papers/1079808 | PubMed |
| 19 | 1,268,947 | The nature of the effector cells mediating mitogen-induced cellular cytotoxicity (MICC) and antibody-dependent cellular cytotoxicity (ADCC). | Cell Immunol | 1976 | https://conductscience.org/library/papers/1268947 | PubMed |
| 20 | 932,431 | Divergent effects of cyclophosphamide administration on mononuclear killer cells: quantitative depletion of cell numbers versus qualitative suppression of functional capabilities. | J Immunol | 1976 | https://conductscience.org/library/papers/932431 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,783,354 | Phosphorylation of deoxyguanosine by B and T lymphocytes: evidence against selective trapping of deoxyguanosine by T lymphocytes in purine nucleoside phosphorylase deficiency. | Clin Exp Immunol | 1980 | https://conductscience.org/library/papers/6783354 | PubMed |
| 495,693 | Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. | Am J Pathol | 1979 | https://conductscience.org/library/papers/495693 | PubMed |
| 312,169 | Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma. A sequential study over 28 days. II. Changes in non-specific (NK, K and T cell) lymphocytoxicity and delayed hypersensitivity skin reactions. | Clin Exp Immunol | 1979 | https://conductscience.org/library/papers/312169 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/668191
GET https://conductscience.org/api/papers/v1/668191/references?page=2